OCS Products Based on Exosome Technology Were Applied in the Recurrence Monitoring Study After the Initial Treatment of Baseline CA125-negative Ovarian Cancer

NCT07153705 · clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
32
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Beihua Kong